| Problem
List |
: |
DISTAL SENSORY NEUROPATHY (13/Jun/2019) | ERECTILE DYSFUNCTION (20/Jun/2018) | TYPE 2 DM (01/Jan/2015) | VITAMIN D INSUFFICIENCY (25/Jan/2022) | DYSSOMNIA (29/Mar/2022) | |
|
Subjective |
: |
HAD PCI,NO NEW COMPLAINTS,CANNOT AFFORD GLP1RA |
|
Objective |
: |
NONE |
|
Analysis |
: |
DISTAL SENSORY NEUROPATHY,TYPE 2 DM,ATHEROSCLEROTIC CARDIOVASCULAR DISEASE |
|
Plan |
: |
ADD DPP4I,SEE ME IN 2 MONTHS WITH TESTING |
|
| Salient Investigations |
: |
BUN BLOOD UREA NITROGEN: 10.7 mg/dL | HEMOGLOBIN: 15.1 g/dL | MCV - MEAN CORPUSCULAR VOLUME: 87 fL | PLATELETS: 131 thou cells/ ul | WBC WHITE BLOOD CELLS: 697 K/uL | FASTING PLASMA GLUCOSE (FPG): 134 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 7.6 % | POST PRANDIAL GLUCOSE (2HPP): 172 mg/dL | NT PROBNP : 103.5 pg/mL | MICROALBUMIN CREATININE RATIO: 27.3 mcg/mg | URINE MICROALBUMINURIA: 16.1 mg/L | FREE T4 : 1.1 ng/dL | TSH : 1.5 mIU/L | CREATININE: 0.9 mg/dL | EGFR EGLOMERULAR FILTRATION RATE: 91.07 mL/min/1.73m2 | HDL HIGH DENSITY LIPOPROTEIN: 32 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 30.8 mg/dL | TGL TRIGLYCERIDE: 176 mg/dL | TOTAL CHOLESTEROL: 98 mg/dl | ALBUMIN (SERUM): 4.8 g/dL | ALKALINE PHOSPHOTASE: 81 IU/L | DIRECT BILIRUBIN: 0.5 mg/dl | SGOT (AST): 38 U/L | SGPT (ALT): 36 IU/L | FIB4: 3.00 | TOTAL BILIRUBIN: 1.7 mg/dL |
